Cargando…

Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer

KRAS is one well-established tumor-driver gene associated with cancer initiation, development, and progression. Nonetheless, comparative studies of the relevance of KRAS across diverse tumors remain sparse. We explored the KRAS expression and prognostic values in diverse cancer types via multiple we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Kaixin, Li, Chengyun, Liu, Yang, Gu, Xueyan, Jiang, Longchang, Shi, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105487/ https://www.ncbi.nlm.nih.gov/pubmed/35563733 http://dx.doi.org/10.3390/cells11091427

Ejemplares similares

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7
por: Chen, Kaijie, et al.
Publicado: (2022)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC
por: Wu, Lei, et al.
Publicado: (2023)

Potential prognostic and immunotherapeutic value of calponin 1: A pan-cancer analysis
por: Zhou, Hengli, et al.
Publicado: (2023)

Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA
por: Wang, Jinju, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2)
por: Jiang, Zhong-Hui, et al.
Publicado: (2022)

Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like
por: Yi, Bocun, et al.
Publicado: (2023)

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

Pan-cancer analyses reveal the immunotherapeutic value of klotho
por: Liang, Jinghao, et al.
Publicado: (2022)

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
por: Huang, Wei, et al.
Publicado: (2023)

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer
por: Luo, Lianghua, et al.
Publicado: (2023)

Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
por: Li, Qi, et al.
Publicado: (2023)

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
por: Dong, Zhen, et al.
Publicado: (2021)

Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer
por: Zhou, Xuan, et al.
Publicado: (2022)

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
por: Pan, Boyu, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analyses of Pyroptosis-Related Genes to Predict Survival and Immunotherapeutic Outcome
por: Wang, Qilin, et al.
Publicado: (2022)

Toll-like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer
por: Maitra, Radhashree, et al.
Publicado: (2017)

Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

Allograft inflammatory factor 1 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Liu, Xin, et al.
Publicado: (2023)

Pan-cancer analysis of the prognostic and immunological role of PAQR4
por: Wang, Kaibin, et al.
Publicado: (2022)

Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer
por: Zhou, Qiming, et al.
Publicado: (2023)

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022)

Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen
por: Babich, Michael, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of matrix metalloproteinase 9
por: Zhang, Jie, et al.
Publicado: (2023)

Pan‐Cancer analyses of Necroptosis‐Related genes as a potential target to predict immunotherapeutic outcome
por: Zhou, Zheng, et al.
Publicado: (2022)

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
por: Arrington, Amanda K., et al.
Publicado: (2012)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response
por: Song, Jing, et al.
Publicado: (2021)

Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer
por: Lei, Jiangchu, et al.
Publicado: (2022)

Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis
por: Zhao, Zhixun, et al.
Publicado: (2022)

FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy
por: Deng, Jiehua, et al.
Publicado: (2022)

A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor
por: Mo, Zhuomao, et al.
Publicado: (2021)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023)

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis
por: Zheng, Xingyu, et al.
Publicado: (2023)

A comprehensive pan-cancer analysis on the immunological role and prognostic value of TYMP in human cancers
por: Yang, Yalan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qpfkoivp0b0503rdslgpl0lvb